
Division Director, Educational Meetings @ASCO. DC native. Poet. Breast cancer survivor. Views are my own.
Joined March 2009
- Tweets2.2K
- Following517
- Followers533
- Likes561
Lisa Greaves retweeted
#ASCO22 attendees— this 2
Minute survey is a perfect thing to do as you travel home! – at Chicago, IL
ASCO Pulse Check📝: If you treat patients with cancer, please take 2 minutes to complete this survey on clinician contentment surveymonkey.com/r/asco_puls… #ASCO22
Lisa Greaves retweeted
We are heartened by progress against cancer. But we cannot overlook current events. Racism cannot be ignored. It undermines public health. We commit to health equity & doing our part to address inequities in research & care for every patient, everywhere, every day.
Lisa Greaves retweeted
Replying to @YJanjigianMD
@YJanjigianMD from MSKCC showing that persistent ctDNA after chemo predicts recurrence after chemotherapy for early stage colon cancer. Is this MRD for GI malignancies? Move over hematologists! #GI20
Lisa Greaves retweeted
Congratulations to Dr Thomas Smith, the 2019 Walther Cancer Foundation awardee at #supponc19 - so well deserved, recognizing a pioneer in the #pallonc world, whose work continues to bring these fields together to benefit our patients and families #hpm #hapc
Lisa Greaves retweeted
The abstract submitter is now open for this year’s GU Cancers Symposium! Submit your research by October 22, 2019 at 11:59 PM (EDT).
Lisa Greaves retweeted
The abstract submitter is now open for this year’s GU Cancers Symposium! Submit your research by October 22, 2019 at 11:59 PM (EDT).
Lisa Greaves retweeted
Got a story to tell? Submit a 3 min audio audition by 11/29/19 to give a 7 min TED-style talk at the unopposed @ASCO Voices session at #ASCO20. No slides, just you & a mic & an audience of your peers in Arie Crown. More here: meetings.asco.org/am/asco-vo…
Lisa Greaves retweeted
The new healthcare ecosystem #ASCOBT19 bringing innovative therapies to all who need it @ASCO @JGO_ASCO @OncoAlert – at Pathum Wan, Thailand
Lisa Greaves retweeted
#GI20 is the leading multidisciplinary event for innovative research in #GIcancers. Submit an abstract by October 1! fal.cn/3409q
Lisa Greaves retweeted
I may say this every year, but it’s worth repeating. Thank you to all patients who participated in the research that makes #ASCO19 and progress in cancer care possible. We owe you our gratitude, and we’ll continue to work hard to make outcomes better.
Lisa Greaves retweeted
Why the Trump Justice Dept refusal to defend the ACA in court is more scary than just the consequences for people with pre-existing health conditions. @nicholas_bagley: it abandons a basic tenet of rule of law. theincidentaleconomist.com/w…
Lisa Greaves retweeted
Just in case you missed it, or wanted to watch it again:
Dr. Bruce Johnson's Presidential Address at #ASCO18
A must. Inspiring. The Prez! @drbrucejohnson @DanaFarber #lcsm connection.asco.org/blogs/20…
Lisa Greaves retweeted
THE WASHINGTON CAPITALS ARE THE 2018 #STANLEYCUP CHAMPIONS! #ALLCAPS
Lisa Greaves retweeted
Twitter 101 and beyond: introduction to social media platforms available to practicing hematologist/oncologists [10/2017] @mtmdphd @AhlstromJenny @drdonsdizon @DrYashGad @chimoose @hjluks @andrewschorr Sem Hematol ow.ly/piRt30kiUsR #ASCO18
Lisa Greaves retweeted
The more diverse your HLA and the more mutations you cancer has, the more likely your immune system can process a mutation that can stimulate a T cell. #asco #sitc #ImmunoOnc18
Lisa Greaves retweeted
Of course, this is true for every conference...not just #ASCO17, but clever. xitter.cf/GlopesMd/status/869884…

























